FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition for transdermal administration has a pH value ranging from 4.0 to 6.0 and has the following composition, wt %: 0,9÷2,0 gestagen, 10÷17,2 melatonin, α-adrenergic blocker tropic to the posterior nucleus of the hypothalamus, 0,9÷2,0, N-methyl-N-(1,2R,3R,4R,5S-pentahydroxyhexyl)-octadecanamide 0,5, D-panthenol 0.5, polyoxyethylated α-tocopherol 10, polyoxyethylared lanolin 1,3-(octadecyloxy)-1,2-propanediol 0,1, stearic acid 1,1, N,N-diethyl toluamide 15, 1,2-isopropylidene glycerol 20, 1,2,3-triacetoxypropane up to 100. The method of controlling the sexual behavior of male animals includes administration of the claimed pharmaceutical composition.
EFFECT: use of the claimed group of inventions allows to effectively regulate the sexual behavior of male mammals in the absence of side effects.
4 cl, 10 tbl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REGULATION OF SEXUAL BEHAVIOR AND CONTRACEPTION OF FEMALE MAMMALS | 2015 |
|
RU2617518C2 |
LIQUID HOMOGENEOUS PHASE FOR TRANSDERMAL PHARMACEUTICAL COMPOSITIONS | 2015 |
|
RU2649809C2 |
HORMONAL AGENT FOR REGULATING SEXUAL HEAT IN SMALL DOMESTIC ANIMALS | 2023 |
|
RU2812129C1 |
2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DICHLOROACETATE, ITS STABLE CRYSTALLINE FORM AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2540070C1 |
METHOD FOR OBTAINING CONTRACEPTIVE PREPARATION FOR ANIMALS | 2003 |
|
RU2268728C2 |
DRUG WITH IMMUNOMODULATORY EFFECT | 2016 |
|
RU2629331C1 |
MEANS AND METHOD FOR IMPROVING SPERM QUALITY | 1999 |
|
RU2159122C1 |
METHOD OF PRODUCING CREATINE AMIDES | 2009 |
|
RU2428414C2 |
MEDICINE FOR TREATMENT AND PREVENTION OF POSTNATAL ENDOMETRITIS AND SYNDROME OF METRITIS-MASTITIS-AGALACTIA IN SOWS | 2011 |
|
RU2464979C1 |
CONTRACEPTIVE METHOD AND REMEDY FOR ANIMALS | 1993 |
|
RU2048149C1 |
Authors
Dates
2017-04-13—Published
2015-08-04—Filed